APYX
Price
$3.99
Change
-$0.04 (-0.99%)
Updated
Dec 11 closing price
Capitalization
163.71M
90 days until earnings call
Intraday BUY SELL Signals
NVCR
Price
$13.30
Change
-$0.36 (-2.64%)
Updated
Dec 12, 01:25 PM (EDT)
Capitalization
1.53B
69 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APYX vs NVCR

Header iconAPYX vs NVCR Comparison
Open Charts APYX vs NVCRBanner chart's image
Apyx Medical
Price$3.99
Change-$0.04 (-0.99%)
Volume$47.77K
Capitalization163.71M
NovoCure
Price$13.30
Change-$0.36 (-2.64%)
Volume$1.22K
Capitalization1.53B
APYX vs NVCR Comparison Chart in %
View a ticker or compare two or three
VS
APYX vs. NVCR commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APYX is a Hold and NVCR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (APYX: $3.99 vs. NVCR: $13.66)
Brand notoriety: APYX and NVCR are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: APYX: 36% vs. NVCR: 123%
Market capitalization -- APYX: $163.71M vs. NVCR: $1.53B
APYX [@Medical/Nursing Services] is valued at $163.71M. NVCR’s [@Medical/Nursing Services] market capitalization is $1.53B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $214.37B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APYX’s FA Score shows that 0 FA rating(s) are green whileNVCR’s FA Score has 1 green FA rating(s).

  • APYX’s FA Score: 0 green, 5 red.
  • NVCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both APYX and NVCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APYX’s TA Score shows that 2 TA indicator(s) are bullish while NVCR’s TA Score has 6 bullish TA indicator(s).

  • APYX’s TA Score: 2 bullish, 6 bearish.
  • NVCR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NVCR is a better buy in the short-term than APYX.

Price Growth

APYX (@Medical/Nursing Services) experienced а -0.99% price change this week, while NVCR (@Medical/Nursing Services) price change was +16.16% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.54%. For the same industry, the average monthly price growth was +0.19%, and the average quarterly price growth was +11.76%.

Reported Earning Dates

APYX is expected to report earnings on Mar 12, 2026.

NVCR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Medical/Nursing Services (-0.54% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCR($1.53B) has a higher market cap than APYX($164M). APYX YTD gains are higher at: 152.532 vs. NVCR (-54.161). APYX has higher annual earnings (EBITDA): -10.64M vs. NVCR (-110.77M). NVCR has more cash in the bank: 912M vs. APYX (29.3M). APYX has less debt than NVCR: APYX (39.1M) vs NVCR (700M). NVCR has higher revenues than APYX: NVCR (630M) vs APYX (46.5M).
APYXNVCRAPYX / NVCR
Capitalization164M1.53B11%
EBITDA-10.64M-110.77M10%
Gain YTD152.532-54.161-282%
P/E RatioN/AN/A-
Revenue46.5M630M7%
Total Cash29.3M912M3%
Total Debt39.1M700M6%
FUNDAMENTALS RATINGS
APYX vs NVCR: Fundamental Ratings
APYX
NVCR
OUTLOOK RATING
1..100
1825
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
3560
P/E GROWTH RATING
1..100
1008
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APYX's Valuation (58) in the Medical Specialties industry is somewhat better than the same rating for NVCR (100). This means that APYX’s stock grew somewhat faster than NVCR’s over the last 12 months.

APYX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVCR (100). This means that APYX’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's SMR Rating (96) in the Medical Specialties industry is in the same range as APYX (99). This means that NVCR’s stock grew similarly to APYX’s over the last 12 months.

APYX's Price Growth Rating (35) in the Medical Specialties industry is in the same range as NVCR (60). This means that APYX’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's P/E Growth Rating (8) in the Medical Specialties industry is significantly better than the same rating for APYX (100). This means that NVCR’s stock grew significantly faster than APYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APYXNVCR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 19 days ago
85%
Bearish Trend 26 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
APYX
Daily Signal:
Gain/Loss:
NVCR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SIGCY12.340.40
+3.35%
SIG GROUP AG
RIOFF1.830.02
+0.94%
RIO2 Limited
KHNGF207.78N/A
N/A
Kuehne & Nagel International AG
NWRLY0.91N/A
N/A
New World Department Store China Ltd.
CDTI0.99-0.01
-1.00%
CDTI Advanced Materials, Inc.

APYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, APYX has been loosely correlated with CORBF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APYX jumps, then CORBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APYX
1D Price
Change %
APYX100%
-0.99%
CORBF - APYX
36%
Loosely correlated
+0.01%
CVRX - APYX
25%
Poorly correlated
-0.24%
CLPT - APYX
25%
Poorly correlated
-1.07%
EMBC - APYX
25%
Poorly correlated
+3.55%
INFU - APYX
25%
Poorly correlated
+1.10%
More

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with QDEL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then QDEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
+3.33%
QDEL - NVCR
41%
Loosely correlated
+3.00%
ENOV - NVCR
41%
Loosely correlated
+0.54%
OFIX - NVCR
39%
Loosely correlated
-0.76%
BLFS - NVCR
39%
Loosely correlated
+0.44%
ALGN - NVCR
38%
Loosely correlated
-0.43%
More